No photo of Scott M Dehm
Contact Expert

View Scopus Profile

Scott M Dehm

20002023

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 3 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Integrative analysis of exitrons in metastatic prostate cancer

Yang, R. & Dehm, S. M.

U.S. DEPARTMENT OF DEFENSE

9/15/19 → 9/14/22

Project: Research project

Transforming precision medicine in lethal prostate cancer using stem cell derived organoids

Dehm, S. M.

Newcastle University

12/15/18 → 12/14/20

Project: Research project

    • Design and evaluation of small molecules that target the dimerization interface of full-length and splice-variant forms of the androgen receptor

    Dehm, S. M.

    U.S. DEPARTMENT OF DEFENSE

    9/1/18 → 8/31/21

    Project: Research project

    • AR gene rearrangements and AR signaling in prostate canc

    Dehm, S. M., Henzler, C., Murugan, P. & Yang, R.

    NIH NATIONAL CANCER INSTITUTE (NCI)

    4/1/18 → 3/31/23

    Project: Research project

    • Molecular Efficacy of Enzalutamide Suppression of Androg

    Dehm, S. M. & Gupta, S.

    ASTELLAS PHARMA, INC.

    12/14/17 → 12/13/20

    Project: Research project

    • Research Output

    Exploitation of CD133 for the Targeted Imaging of Lethal Prostate Cancer

    Glumac, P. M., Gallant, J. P., Shapovalova, M., Li, Y., Murugan, P., Gupta, S., Coleman, I. M., Nelson, P. S., Dehm, S. M. & Lebeau, A. M., Mar 1 2020, In : Clinical Cancer Research. 26, 5, p. 1054-1064

    Research output: Contribution to journal › Article

    A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities

    Kounatidou, E., Nakjang, S., McCracken, S. R. C., Dehm, S. M., Robson, C. N., Jones, D. & Gaughan, L., Jan 1 2019, In : Nucleic acids research. 47, 11, p. 5634-5647 14 p.

    Research output: Contribution to journal › Article

    Open Access
    • 2 Scopus citations

    A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer

    Warren, A. Y., Massie, C. E., Watt, K., Luko, K., Orafidiya, F., Selth, L. A., Mohammed, H., Chohan, B. S., Menon, S., Baridi, A., Zhao, W., Escriu, C., Pungsrinont, T., D’Santos, C., Yang, X., Taylor, C., Qureshi, A., Zecchini, V. R., Shaw, G. L., Dehm, S. M. & 7 others, Mills, I. G., Carroll, J. S., Tilley, W. D., McEwan, I. J., Baniahmad, A., Neal, D. E. & Asim, M., Feb 14 2019, In : Oncogene. 38, 7, p. 1136-1150 15 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    Ar-variant–positive CTC: A surrogate for a surrogate for taxane therapy outcome?

    Dehm, S. M., Montgomery, B. & Plymate, S. R., Jan 1 2019, In : Clinical Cancer Research. 25, 6, p. 1696-1698 3 p.

    Research output: Contribution to journal › Article

    • 2 Scopus citations

    CK2 pro-survival role in prostate cancer is mediated via maintenance and promotion of androgen receptor and NFκB p65 expression

    Trembley, J. H., Kren, B. T., Abedin, M. J., Shaughnessy, D. P., Li, Y., Dehm, S. M. & Ahmed, K., Jun 2019, In : Pharmaceuticals. 12, 2, 89.

    Research output: Contribution to journal › Article

    Open Access